归因于胃食管反流病的食管外症状与疾病:当前钟摆摆向何方?
本综述概述食管外反流病领域近期进展并给出临床相关推荐,推荐基于专家意见及PubMed和EMbase相关文献,由美国胃肠病学会临床实践更新委员会提出9条最佳实践建议,涉及胃肠病学评估角色、非胃肠评估必要性、经验性抑酸治疗、检测方法选择及手术适应证等。
要点
- 胃肠病学家的作用是评估可能引起食管外症状的胃食管病因,非胃肠评估(耳鼻喉、肺、过敏)常应初始进行。
- 经验性强化抑酸治疗6-8周并关注食管外症状反应有助于评估反流与症状的关联。
- 无单一检测方法可明确反流为食管外症状病因,需结合表现、检测结果和治疗反应综合判断。
核心结论
- 食管外反流的评估需综合患者表现、检测结果和治疗反应,手术仅考虑用于有机械缺陷、基线中重度反流且保守治疗失败者。
研究设计与样本
- 本综述基于专家意见及PubMed和EMbase相关文献,由美国胃肠病学会临床实践更新委员会提出最佳实践建议。
主要发现
- 经验性强化抑酸治疗6-8周并关注食管外症状反应可帮助评估反流与症状的关联。
- 无单一检测方法可明确反流为疑似食管外症状的病因。
- 对强化抑酸治疗无反应且停药pH检测正常或治疗中阻抗-pH检测正常,显著降低反流作为 contributing 病因的可能性。
关键数值与推荐
- 最佳实践建议1:胃肠病学家应评估可能引起食管外症状的胃食管病因。
- 最佳实践建议2:耳鼻喉、肺和/或过敏的非胃肠评估至关重要,多数患者常应初始进行。
- 最佳实践建议3:经验性强化抑酸治疗6-8周并关注食管外症状反应有助于评估关联。
- 最佳实践建议4:无单一检测方法可明确反流为疑似食管外症状的病因。
- 最佳实践建议5:应结合患者表现、检测结果和治疗反应判断反流作为可能病因。
临床怎么用
- 胃肠病学家应评估可能引起食管外症状的胃食管病因,非胃肠评估常应初始进行。
- 可经验性强化抑酸治疗6-8周并关注食管外症状反应以评估关联。
- 根据患者人口学特征和症状选择PPI治疗中或停药检测,高基线反流概率者考虑治疗中检测,低概率者考虑停药检测。
- 对强化抑酸治疗无反应且检测正常者,反流作为病因的可能性显著降低。
- 对强化PPI治疗无反应者不鼓励外科胃底折叠术,手术仅考虑用于有机械缺陷、基线中重度反流且保守治疗失败者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The purpose of this review is to outline the recent developments in the field of extraesophageal reflux disease and provide clinically relevant recommendations. The recommendations outlined in this review are based on expert opinion and on relevant publications from PubMed and EMbase. The Clinical Practice Updates Committee of the American Gastroenterological Association proposes the following recommendations: Best Practice Advice 1: The role of a gastroenterologist in patients referred for evaluation of suspected extra esophageal symptom is to assess for gastroesophageal etiologies that could contribute to the presenting symptoms. Best Practice Advice 2: Non-GI evaluations by ENT, pulmonary and/or allergy are essential and often should be performed initially in most patients as the cause of the extraesophageal symptom is commonly multifactorial or not esophageal in origin. Best Practice Advice 3: Empiric therapy with aggressive acid suppression for 6-8 weeks with special focus on response of the extraesophageal symptoms can help in assessing association between reflux and extraesophageal symptoms. Best Practice Advice 4: No single testing methodology exists to definitively identify reflux as the etiology for the suspected extra esophageal symptoms. Best Practice Advice 5: Constellation of patient presentation, diagnostic test results and response to therapy should be employed in the determination of reflux as a possible etiology in extra esophageal symptoms. Best Practice Advice 6: Testing may need to be off or on proton pump inhibitor (PPI) therapy depending on patients' presenting demographics and symptoms in assessing the likelihood of abnormal gastroesophageal reflux. A. On therapy testing may be considered in those with high probability of baseline reflux (those with previous esophagitis, Barrett's esophagus or abnormal pH). B. Off therapy testing may be considered in those with low probability of baseline reflux with the goal of identifying moderate to severe reflux at baseline. Best Practice Advice 7: Lack of response to aggressive acid suppressive therapy combined with normal pH testing off therapy or impedance-pH testing on therapy significantly reduces the likelihood that reflux is a contributing etiology in presenting extraesophageal symptoms. Best Practice Advice 8: Surgical fundoplication is discouraged in those with extra esophageal reflux symptoms unresponsive to aggressive PPI therapy. Best Practice Advice 9: Fundoplication should only be considered in those with a mechanical defect (e.g., hiatal hernia), moderate to severe reflux at baseline off PPI therapy who have continued reflux despite PPI therapy and have failed more conservative non-GI treatments.
引用
- Vaezi MF, Katzka D, Zerbib F, et al. Extraesophageal Symptoms and Diseases Attributed to GERD: Where is the Pendulum Swinging Now? Clin Gastroenterol Hepatol. 2018. PMID: 29427733. doi:10.1016/j.cgh.2018.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。